Sign in
Taking peopleNo phase

Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis

Key facts

Who runs it
Qianfoshan Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
140 people, planned
Started
10 May 2025
Expected to end
31 Jan 2029
Type of study
Observational, 3 groups
Record updated
4 July 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (10)Hide the full registry criteria

Who can take part

  • Meets the diagnostic criteria for allergic bronchopulmonary aspergillosis
  • Meets the diagnostic criteria for fungal-sensitized asthma

Who cannot take part

  • Human immunodeficiency virus infection
  • Malignant tumor
  • Blood system disease
  • autoimmune system disease
  • History of pulmonary tuberculosis
  • Patients with a history of smoking or still smoking
  • Invasive pulmonary fungal disease
  • Contraindications electronic bronchoscopy

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Allergic bronchopulmonary aspergillosis

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to reveal the immune and inflammatory regulatory molecular mechanisms related to the progression of allergic bronchopulmonary aspergillosis (ABPA), and to build a precision typing based on inflammation and identify the biomarkers of typing, and to explore the clinical outcomes of different inflammatory phenotypes.

The 3 groups in the trial

  • allergic bronchopulmonary aspergillosis
  • fungal-sensitized asthma
  • control group

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT07040332, who can take part
Record updated
4 July 2025